English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

© 2015 Egyptian Journal of Bronchology | Published by Wolters Kluwer Medknow DOI: 10.4103/1687-8426.165938 Multiple myeloma (MM) is a systemic disease primarily involving the bone marrow, constituting about 1% of all malignancies and 10% of hematological malignancies [1]. It is a neoplastic proliferation of monoclonal plasma cells that can result in renal impairment, osteolytic lesions, hypercalcemia, bone marrow failure, and the production of serum monoclonal proteins. Although usually restricted to the bone marrow, extraskeletal spread in the form of plasmacytoma, which represent localized extramedullary collections of malignant plasma cells, can occur in a significant number of patients. However, symptomatic pulmonary involvement during the course of MM has rarely been reported [2].

Pulmonary plasmacytoma in multiple myeloma: a rare case of extramedullary spread